Concepedia

SARS-CoV-2 DNA Vaccine INO-4800 Induces Durable Immune Responses Capable of Being Boosted in a Phase 1 Open-Label Trial

Kimberly A. Kraynyak, Elliott Blackwood, Joseph Agnes, Pablo Tebas, Mary Giffear, Dinah Amante, Emma L. Reuschel, Mansi Purwar, Aaron Christensen-Quick, Neiman Liu,

The Journal of Infectious Diseases · 2022 · 59 citations · 13 references

DOIFull text

Open access

Abstract

NCT04336410.

References

13

Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein

Alexandra C. Walls, Young‐Jun Park, M. Alejandra Tortorici et al. · Cell · 2020 · 9K citations · Full text

, , +4

Antigen-Specific Adaptive Immunity to SARS-CoV-2 in Acute COVID-19 and Associations with Age and Disease Severity

Carolyn Rydyznski Moderbacher, Sydney I. Ramirez, Jennifer M. Dan et al. · Cell · 2020 · 1.9K citations · Full text

Immunogenicity of a DNA vaccine candidate for COVID-19

Trevor R.F. Smith, Ami Patel, Stephanie Ramos et al. · Nature Communications · 2020 · 635 citations · Full text

Addressing the Cold Reality of mRNA Vaccine Stability

Daan J.A. Crommelin, Thomas J. Anchordoquy, David B. Volkin et al. · Journal of Pharmaceutical Sciences · 2020 · 487 citations · Full text

Safety and Immunogenicity of an Anti–Zika Virus DNA Vaccine

New England Journal of Medicine · 2017 · 309 citations · Full text